Results 1 to 10 of about 5,292 (153)

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study

Health Science Reports, 2023
Background and Aims The FORMA‐05 study compared the efficacy and safety of human fibrinogen concentrate (HFC) versus cryoprecipitate for hemostasis in bleeding patients undergoing cytoreductive surgery for pseudomyxoma peritonei (PMP).
Ashok Roy, Nigel Sargant, John Bell, Sophia Stanford, Cristina Solomon, Irina Kruzhkova, Sigurd Knaub, Faheez Mohamed   +7 more
doaj   +1 more source

Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review

World Journal of Surgical Oncology
Abstract Surgery-based multimodality therapies for treatment of malignant pleural mesothelioma have been clinically explored in the past decades. In this regard, hyperthermic intrathoracic or intrapleural chemotherapy has been used as one of the multimodality therapies.
Hany Hasan Elsayed, Mohamed Elanany Elsaid Elanany, Mohamed Tarek ElSayegh, Aly Sherif Hassaballa, Mohammed Abdel-gayed   +4 more
openaire   +3 more sources

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

The Scientific World Journal, 2013
Background. Prolonged survival of patients affected by peritoneal metastasis (PM) of colorectal origin treated with complete cytoreduction followed by intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been reported. However, two-thirds
Yutaka Yonemura, Emel Canbay, Haruaki Ishibashi   +2 more
doaj   +1 more source

Impact of fluid and haemodynamic management in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on postoperative outcomes – A systematic review

Indian Journal of Anaesthesia, 2023
Background and Aims: Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an extensive surgery associated with significant fluid shift and blood loss.
Sohan Lal Solanki, Indubala Maurya, Jyoti Sharma   +2 more
doaj   +1 more source

Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients

Patient Safety in Surgery, 2012
Background For recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (CRS) followed by adjuvant chemotherapy is a therapeutic option.
Warschkow Rene, Tarantino Ignazio, Lange Jochen, Müller Sascha A, Schmied Bruno M, Zünd Michael, Steffen Thomas   +6 more
doaj   +1 more source

Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis

Frontiers in Neurology, 2017
BackgroundUnlike many other central nervous system (CNS) tumors, the surgical management of primary central nervous system lymphomas (PCNSL) is traditionally limited by diagnostic biopsy.
Jonathan Yun, Jingyan Yang, Michael Cloney, Amol Mehta, Suprit Singh, Fabio Massaiti Iwamoto, Alfred I. Neugut, Alfred I. Neugut, Alfred I. Neugut, Adam M. Sonabend   +9 more
doaj   +1 more source

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

The Ewha Medical Journal, 2023
In stage IV colorectal cancer (CRC), peritoneal metastasis is associated with a poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is an effective treatment option ...
Youngbae Jeon, Eun Jung Park
doaj   +1 more source

Robotic Surgery Versus Conventional Laparoscopy and Laparotomy for Ovarian Cancer: A Systematic Review and Meta-analysis [PDF]

Journal of Kerman University of Medical Sciences
Background: This research aimed to evaluate differences in overall survival, recurrence frequency, and both intraoperative and postoperative results in ovarian cancer (OC) patients treated with robotic surgery, laparoscopic procedures, or open laparotomy.
Seyedeh Azam Pourhoseini, Leili Hafizi, Shadi Moloughi, Amin Dalili   +3 more
doaj   +1 more source

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany

BMJ Open, 2020
Introduction Objective of the ‘German hyperthermic intrathoracic chemotherapy (HITOC) study’ is to evaluate the HITOC as additional treatment after surgical cytoreduction for malignant pleural tumours.
Gunnar Huppertz, Hauke Winter, Rudolf Hatz, Till Markowiak, Florian Zeman, Hans-Stefan Hofmann, Michael Ried, Martin Eichhorn, Laura Klotz, Julia Zimmermann, Julia Kovacs, Bernward Passlick, Severin Schmid, Mohamed Hassan   +13 more
doaj   +1 more source

Spectral CT in peritoneal carcinomatosis from ovarian cancer: a tool for differential diagnosis of small nodules?

European Radiology Experimental, 2022
The detection of peritoneal carcinomatosis in patients with ovarian cancer is crucial to establish the correct therapeutic planning (debulking surgery versus neoadjuvant chemotherapy).
Giada Zorzetto, Andrea Coppola, Valeria Molinelli, Maria Gloria Angeretti, Jvan Casarin, Federico Fontana, Filippo Piacentino, Giulio Carcano, Fabio Ghezzi, Massimo Venturini   +9 more
doaj   +1 more source